Israel Englander’s enGene Therapeutics Warrants ENGNW Stock Holding History

Israel Englander’s Portfolio ENGNW Stock Details ENGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20K	Hold	69,000	–	–	﹤0.01%	5694
2026 Q1	$175K	Hold	69,000	–	–	﹤0.01%	5223
2025 Q4	$204K	Hold	69,000	–	–	﹤0.01%	5468
2025 Q3	$49K	Hold	69,000	–	–	﹤0.01%	5805
2025 Q2	$56.6K	Hold	69,000	–	–	﹤0.01%	5597
2025 Q1	$41.4K	Hold	69,000	–	–	﹤0.01%	5561
2024 Q4	$58.2K	Hold	69,000	–	–	﹤0.01%	5570
2024 Q3	$145K	Hold	69,000	–	–	﹤0.01%	5518
2024 Q2	$95.9K	Hold	69,000	–	–	﹤0.01%	5318
2024 Q1	$359K	Hold	69,000	–	–	﹤0.01%	5028
2023 Q4	$58.6K	Buy	+69,000	New	+$53K	﹤0.01%	5446

Other funds holding ENGNW

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return